Brian David Archbold Sells 2,516 Shares of Mesa Laboratories (NASDAQ:MLAB) Stock

Mesa Laboratories, Inc. (NASDAQ:MLAB) SVP Brian David Archbold sold 2,516 shares of the company’s stock in a transaction on Monday, June 22nd. The stock was sold at an average price of $89.50, for a total transaction of $225,182.00. Following the transaction, the senior vice president owned 6,377 shares of the company’s stock, valued at approximately $570,741.50. This represents a 28.29% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website.

Brian David Archbold also recently made the following trade(s):

• On Tuesday, June 16th, Brian David Archbold sold 1,151 shares of Mesa Laboratories stock. The shares were sold at an average price of $101.27, for a total transaction of $116,561.77.

Mesa Laboratories Price Performance

MLAB stock traded up $1.05 during mid-day trading on Tuesday, hitting $94.28. The company had a trading volume of 64,805 shares, compared to its average volume of 138,158. The company has a 50-day moving average price of $101.95 and a 200 day moving average price of $90.98. Mesa Laboratories, Inc. has a 12-month low of $55.45 and a 12-month high of $113.99. The company has a market capitalization of $520.90 million, a price-to-earnings ratio of 78.57 and a beta of 0.94. The company has a quick ratio of 1.29, a current ratio of 1.72 and a debt-to-equity ratio of 0.78.

Mesa Laboratories (NASDAQ:MLAB) last issued its quarterly earnings data on Wednesday, May 27th. The medical instruments supplier reported $1.53 earnings per share for the quarter, missing analysts’ consensus estimates of $1.78 by ($0.25). Mesa Laboratories had a net margin of 2.69% and a return on equity of 20.96%. The firm had revenue of $63.72 million for the quarter, compared to analysts’ expectations of $65.21 million. During the same quarter in the previous year, the business earned ($1.31) EPS.

Mesa Laboratories Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Monday, June 15th. Shareholders of record on Friday, May 29th were issued a dividend of $0.16 per share. This represents a $0.64 annualized dividend and a yield of 0.7%. The ex-dividend date was Friday, May 29th. Mesa Laboratories’s dividend payout ratio (DPR) is currently 53.33%.

Hedge Funds Weigh In On Mesa Laboratories

A number of institutional investors and hedge funds have recently made changes to their positions in the business. Northwestern Mutual Wealth Management Co. increased its holdings in shares of Mesa Laboratories by 5,366.7% in the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 328 shares of the medical instruments supplier’s stock worth $26,000 after buying an additional 322 shares during the last quarter. Caitong International Asset Management Co. Ltd bought a new position in shares of Mesa Laboratories in the 4th quarter valued at about $27,000. Kestra Advisory Services LLC bought a new position in shares of Mesa Laboratories in the 4th quarter valued at about $55,000. BNP Paribas Financial Markets grew its position in Mesa Laboratories by 115.3% in the second quarter. BNP Paribas Financial Markets now owns 786 shares of the medical instruments supplier’s stock worth $74,000 after acquiring an additional 421 shares in the last quarter. Finally, Tower Research Capital LLC TRC grew its position in Mesa Laboratories by 432.9% in the second quarter. Tower Research Capital LLC TRC now owns 842 shares of the medical instruments supplier’s stock worth $79,000 after acquiring an additional 684 shares in the last quarter. 90.60% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings cut Mesa Laboratories from a “sell (d+)” rating to a “sell (d)” rating in a report on Wednesday, June 3rd. Two investment analysts have rated the stock with a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, Mesa Laboratories currently has an average rating of “Reduce” and an average target price of $94.00.

Mesa Laboratories Company Profile

Mesa Laboratories, Inc (NASDAQ: MLAB) is a global provider of instrumentation products designed for critical process monitoring, testing and calibration. Headquartered in Lakewood, Colorado, the company serves a diverse set of end markets including healthcare, pharmaceutical, food and beverage, energy and industrial sectors. With a focus on precision measurement and validation, Mesa Laboratories helps customers ensure regulatory compliance, product safety and operational efficiency across complex manufacturing and sterilization processes.

The company’s product portfolio encompasses biological and chemical indicators for sterilization process validation, digital data loggers and sensors for environmental monitoring, and optical gas analyzers with sample-conditioning solutions for oil, gas and petrochemical applications.